Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 3/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | CCR8 | P51685 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL634061 | 1.00 | KCNH2 (0.41) | KCNH2TRPV1CCR8 | |
| SCHEMBL632747 | 1.00 | KCNH2 (0.41) | KCNH2TRPV1CCR8 | |
| SCHEMBL632725 | 0.95 | KCNH2 (0.41) | KCNH2 | |
| SCHEMBL632757 | 0.88 | SIGMAR1 (0.37) | KCNH2CCR8 | |
| SCHEMBL633729 | 0.88 | SIGMAR1 (0.37) | KCNH2CCR8 | |
| SCHEMBL632610 | 0.86 | KCNH2 (0.36) | KCNH2 | |
| SCHEMBL632609 | 0.86 | KCNH2 (0.36) | KCNH2 | |
| SCHEMBL632891 | 0.85 | KCNH2 (0.36) | KCNH2CCR8 | |
| SCHEMBL632746 | 0.85 | KCNH2 (0.36) | KCNH2CCR8 | |
| SCHEMBL632738 | 0.85 | KCNH2 (0.36) | KCNH2CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2245028-B1 | 5-AMINOCYCLYLMETHYL-OXAZOLIDIN-2-ONE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2012-02-22 | — | — | EP | disclosed |
| US-20110003789-A1 | 5-AMINOCYCLYLMETHYL-OXAZOLIDIN-2-ONE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003789-A1 | 5-AMINOCYCLYLMETHYL-OXAZOLIDIN-2-ONE DERIVATIVES | CNKSR1, KCNH1, CBR3 | KCNH2 31/4885TRPV1 4039/4885CCR8 387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.